News Quantified

ANVS – annovis bio, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Annovis Bio, Inc. (NYSE: ANVS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.

Annovis Bio, Inc. (NYSE: ANVS) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $36.00 to $26.00. They now have a "buy" rating on the stock.

Annovis Bio: Searching For Efficacy In Alzheimer's Disease [Seeking Alpha]

UPDATE 1-Annovis' Alzheimer's treatment helps improve cognition in trial [Yahoo! Finance]

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer's Disease [Yahoo! Finance]

-2.5%

BEAT

-0.1%

MISS

Canaccord Genuity

Form ARS Annovis Bio, Inc. For: Dec 31

Form DEFA14A Annovis Bio, Inc.

Form DEF 14A Annovis Bio, Inc. For: Jun 12

Form 8-K Annovis Bio, Inc. For: Apr 25

Form 8-K Annovis Bio, Inc. For: Apr 02

Top News Gainers

1/28 Annovis Bio Announces Pricing of Initial Public Offering 44.6%

4/3 Form 8-K Annovis Bio, Inc. For: Apr 03 15.0%

2/13 Annovis Bio Announces Update on Phase II Clinical Trial for Alzheimer’s Disease 10.5%

4/13 Annovis Bio to Hold Investor Webinar and Q&A Session with CEO on April 14 5.8%

4/30 Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients 5.3%

1/31 Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 3.4%

3/25 Form 10-K Annovis Bio, Inc. For: Dec 31 2.3%

4/20 Form SC 13D Annovis Bio, Inc. Filed by: Maccecchini Maria-Luisa 1.3%

4/23 Annovis Bio Publishes Results of Alzheimer’s and Parkinson’s Animal Studies 0.3%

Top News Decliners

1/30 Form 424B4 Annovis Bio, Inc. -26.7%

2/14 Form S-8 Annovis Bio, Inc. -10.3%

2/6 Form 8-K Annovis Bio, Inc. For: Jan 30 -9.3%

3/19 Annovis Bio to Present at the Online Spring Investor Summit on March 25 -7.0%

5/1 Annovis Bio Interview to Air on Bloomberg International on the RedChip Money Report -3.9%

2/20 Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases -3.2%

2/5 Form 4 Annovis Bio, Inc. For: Jan 31 Filed by: Bruck Claudine -2.9%

4/15 Annovis up 23% after webinar on neurodegeneration candidates [Seeking Alpha] -2.6%

2/27 Annovis Awarded $1.7 Million NIH Grant for ANVS401 Chronic Toxicology Studies -0.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day